24,890.9
(47.75)
(0.19%)
21 May , 2026 | 04:14 PM
Open
24,994.1
Prev. Close
24,843.15
Market Cap.
₹19,48,148.63
Div Yield
0.63
PE
38.9
PB
38.9
24,782.65
25,001
Performance
One Week (%)
3.96
One Month (%)
10.62
One Year (%)
15.78
YTD (%)
12.86
Company Name | CMP | High | Low | Volume |
|---|---|---|---|---|
Abbott India Ltd | 27,715 | 27,880 | 27,495 | 6,955 |
Cipla Ltd | 1,401.9 | 1,415.9 | 1,397.7 | 11,45,360 |
J B Chemicals & Pharmaceuticals Ltd | 2,178.9 | 2,194.9 | 2,154.5 | 4,17,886 |
Dr Reddys Laboratories Ltd | 1,318.5 | 1,331.6 | 1,314.2 | 21,83,121 |
Lupin Ltd | 2,284.5 | 2,304.3 | 2,269.6 | 12,24,058 |
Torrent Pharmaceuticals Ltd | 4,469.2 | 4,517.7 | 4,444.2 | 2,45,755 |
Ipca Laboratories Ltd | 1,637 | 1,660 | 1,619 | 2,20,532 |
Sun Pharmaceutical Industries Ltd | 1,891.3 | 1,899.6 | 1,868.1 | 16,05,806 |
Aurobindo Pharma Ltd | 1,546.7 | 1,550 | 1,515.5 | 10,13,775 |
Wockhardt Ltd | 1,599.8 | 1,638.7 | 1,594.6 | 7,61,546 |
Ajanta Pharma Ltd | 3,149.2 | 3,220 | 3,140.1 | 54,083 |
Gland Pharma Ltd | 2,331 | 2,370 | 2,230 | 10,19,484 |
Biocon Ltd | 430.85 | 436.75 | 429.1 | 26,83,900 |
Alkem Laboratories Ltd | 5,501.5 | 5,604 | 5,416 | 1,00,493 |
Glenmark Pharmaceuticals Ltd | 2,393 | 2,407.8 | 2,372 | 3,81,349 |
Zydus Lifesciences Ltd | 1,036.45 | 1,054 | 1,030.05 | 19,20,511 |
Divis Laboratories Ltd | 6,858 | 6,925 | 6,829 | 1,51,586 |
Mankind Pharma Ltd | 2,514.1 | 2,638.6 | 2,497.7 | 18,13,187 |
Laurus Labs Ltd | 1,351 | 1,373.9 | 1,342.2 | 20,56,966 |
Piramal Pharma Ltd | 176.08 | 178 | 174.52 | 19,83,146 |
Indian benchmark indices ended marginally lower on May 21, 2026, with Nifty closing near 23,654 and Sensex slipping 135 points amid concerns over RBI rate hikes, weak manufacturing PMI, rising crude oil prices, rupee weakness, and renewed FII selling. Defence and Realty stocks supported the market, while IT, FMCG, and Media remained under pressure.
21 May 2026|05:18 PM
Indian benchmark indices staged a strong intraday recovery on May 18, 2026, despite a sharp opening selloff caused by escalating US-Iran tensions, Brent crude crossing $111 per barrel, and the rupee hitting record lows. IT and pharma stocks supported the rebound as Nifty and Sensex closed marginally in the green.
18 May 2026|05:10 PM
Indian benchmark indices ended slightly lower on May 15, 2026, amid record rupee weakness, surging crude oil prices, and cautious global sentiment. While IT, FMCG, and Pharma sectors provided support, heavy selling in Metal, Defence, PSU Bank, Realty, and Oil & Gas stocks kept markets under pressure. Tata Motors Passenger Vehicles and Kirloskar Oil Engines emerged among key gainers after strong quarterly earnings, while Voltas declined sharply on margin pressure concerns.
15 May 2026|05:27 PM
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.